Grace Therapeutics, Inc. (ACST)
3.90
-0.05
(-1.27%)
USD |
NASDAQ |
Feb 19, 16:00
Grace Therapeutics EBITDA Margin (Quarterly)
EBITDA Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EBITDA Margin Definition
EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
EBITDA Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median